Impact of anti-centromere antibodies on pulmonary function test results in patients with systemic sclerosis without established or suspected pulmonary disease

Clinical Rheumatology

Volumn 33, Issue 6, 2014, Pages 869-871

  Gunn, J ^a   Pauling, J D ^a,b   McHugh, N J ^a,b  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Clinical practice; Forced vital capacity; Gas transfer; Pulmonary artery hypertension; Pulmonary function tests; Screening; Systemic sclerosis; TLco

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; ANTIBODY;

ARTICLE; CASE CONTROL STUDY; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION; LUNG FUNCTION TEST; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SYSTEMIC SCLEROSIS; AGED; BLOOD; CENTROMERE; CHEMISTRY; COMPLICATION; IMMUNOLOGY; LUNG DISEASE; MIDDLE AGED; REPRODUCIBILITY; TREATMENT OUTCOME;

AGED; ANTIBODIES; CASE-CONTROL STUDIES; CENTROMERE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 84903816637     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2616-0     Document Type: Article

References (7)

1. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J et al (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62(11):1088-1093 (Pubitemid 37323574)
2. Steen V, Medsger TA Jr (2003) Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 48(2):516-522 (Pubitemid 36278021)
3. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR et al (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119(16):2250-2294
4. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Heart. 2008 Mar;94 Suppl 1:i1-41
5. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202-205 (Pubitemid 18073738)
6. Steen VD, Powell DL, Medsger TA Jr (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31(2):196-203 (Pubitemid 18088039)
7. Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE et al (2008) Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 35(3):458-465 (Pubitemid 351374421)